| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Interferon-induced helicase C domain-containing protein 1, EC:3.6.4.13, Clinically amyopathic dermatomyositis autoantigen 140 kDa, CADM-140 autoantigen, Helicase with 2 CARD domains, Helicard, Interferon-induced with helicase C domain protein 1, Melanoma differentiation-associated protein 5, MDA-5, Murabutide down-regulated protein, RIG-I-like receptor 2, RLR-2, RNA helicase-DEAD box protein 116, IFIH1, MDA5, RH116 |
| Clonality | |
| Form | Liquid |
| Host | |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target |
Overview
Antibody against MDA5/IFIH1 (Interferon-induced helicase C domain-containing protein 1) for research detection of protein expression and localization.
Target biology
Interferon-induced helicase C domain-containing protein 1 is a helicase-family ATPase that remodels nucleic acids and/or ribonucleoprotein complexes. Helicases are central to replication, transcription, splicing and DNA damage responses and are frequently studied in genome maintenance and RNA biology.
Expected localization
Often nuclear (DNA/RNA processing sites), with shuttling or cytoplasmic pools depending on function.
Research context
This target is frequently studied in the context of Oxidative Stress research. Application suitability (e.g., ELISA, WB) is indicated in the specifications; conditions should be optimized by titration. Species reactivity information is provided in the specifications (reported: Human).
Recommended experimental notes
- For Western blotting, optimize lysis conditions and include reducing/non-reducing conditions as appropriate; titrate antibody to balance sensitivity and background.
- For ELISA, ensure capture/detection antibody compatibility and run a standard curve; verify sample matrix effects with spike-and-recovery and dilution linearity.
Controls & interpretation
Where possible, confirm specificity using genetic perturbation (KO/KD/CRISPR), peptide competition (if applicable), or an orthogonal readout. Include a negative control sample expected to express low/none of MDA5/IFIH1, and a positive control sample known to express MDA5/IFIH1.
For research use only. Not for diagnostic procedures.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.